ObsEva Announces Two Cornerstone Publications Describing Clinical Trials of Nolasiban for ...
Press release content from Globe Newswire. The AP news staff was not involved in its creation. ObsEva Announces Two Cornerstone Publications Describing Clinical Trials of Nolasiban for ... ObsEva SAAugust 4, 2021 GMT - s - Published - Geneva, Switzerland and Boston, MA – August 4, 2021 – ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a biopharmaceutical company developing and commercializing novel therapies to improve women’s reproductive health, today announced the publication of two peer-reviewed papers on nolasiban, an oxytocin receptor antagonist in development for improving live birth ra...
Source: apnews.com